SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 194 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $28,000 | -40.4% | 21,722 | 0.0% | 0.00% | – |
Q3 2021 | $47,000 | -42.0% | 21,722 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $81,000 | +14.1% | 21,722 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $71,000 | -4.1% | 21,722 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $74,000 | -16.9% | 21,722 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $89,000 | +21.9% | 21,722 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $73,000 | +43.1% | 21,722 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $51,000 | -35.4% | 21,722 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $79,000 | -56.1% | 21,722 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $180,000 | -3.7% | 21,722 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $187,000 | -19.4% | 21,722 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $232,000 | +22.1% | 21,722 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $190,000 | -47.9% | 21,722 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $365,000 | -24.0% | 21,722 | -5.2% | 0.00% | -33.3% |
Q2 2018 | $480,000 | +30.1% | 22,922 | 0.0% | 0.01% | +50.0% |
Q1 2018 | $369,000 | -16.5% | 22,922 | -1.6% | 0.00% | -20.0% |
Q4 2017 | $442,000 | +132.6% | 23,300 | +72.6% | 0.01% | +150.0% |
Q3 2017 | $190,000 | +88.1% | 13,500 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $101,000 | +14.8% | 13,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $88,000 | +46.7% | 13,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $60,000 | -4.8% | 13,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $63,000 | -29.2% | 13,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $89,000 | +3.5% | 13,500 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $86,000 | +6.2% | 13,500 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $81,000 | 0.0% | 13,500 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $81,000 | -12.0% | 13,500 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $92,000 | +12.2% | 13,500 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $82,000 | -12.8% | 13,500 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $94,000 | -14.5% | 13,500 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $110,000 | 0.0% | 13,500 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $110,000 | +3.8% | 13,500 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $106,000 | -10.9% | 13,500 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $119,000 | -22.7% | 13,500 | -26.6% | 0.00% | 0.0% |
Q3 2013 | $154,000 | +43.9% | 18,400 | +28.7% | 0.00% | 0.0% |
Q2 2013 | $107,000 | – | 14,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,518,000 | 1.37% |
CM Management, LLC | 600,000 | $774,000 | 0.65% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $22,059,000 | 0.43% |
Sargent Investment Group, LLC | 414,600 | $535,000 | 0.14% |
Ergoteles LLC | 299,005 | $386,000 | 0.02% |
Sonora Investment Management Group, LLC | 82,000 | $106,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $55,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $138,000 | 0.01% |
Crestline Management, LP | 66,209 | $85,000 | 0.01% |
D. E. Shaw & Co., Inc. | 7,845,726 | $10,121,000 | 0.01% |